Sanara MedTech Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SMTI, updated each market day.
SMTI AI Sentiment
AI predicts Sanara MedTech Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Sanara MedTech Inc. Common Stock
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Sector
Exchange
Market Cap
$155,564,668
Cap Tier
Employees
108
Headquarters
FORT WORTH, TX
Listed Since
Nov. 2, 2020
Website
SMTI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SMTI Volatility
Sanara MedTech Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
